INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 169 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,909,000 | +181.6% | 46,055 | +722.4% | 0.05% | +500.0% |
| Q2 2017 | $678,000 | -32.7% | 5,600 | -8.6% | 0.01% | -38.5% |
| Q3 2016 | $1,008,000 | -15.9% | 6,124 | +44.1% | 0.01% | -61.8% |
| Q1 2015 | $1,198,000 | +327.9% | 4,249 | +259.2% | 0.03% | +161.5% |
| Q3 2014 | $280,000 | -91.7% | 1,183 | -91.7% | 0.01% | -90.6% |
| Q2 2014 | $3,362,000 | +918.8% | 14,204 | +1320.4% | 0.14% | +557.1% |
| Q1 2014 | $330,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |